Showing results (281-290 of 401) with videos related to
Sort By:
Pageof 41
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Myeloablative Unrelated Cord Blood Transplantation in Adolescents and Young Adults with Acute LeukemiaHiromi Hayashi, Fernanda Volt, Jaime Sanz, et al.Frontiers in Immunology|February 18, 2025
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcomaLaura M Moser, Catrin Heim, Sebastian E Koschade, et al.Nature Medicine|November 21, 2017
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapyTerry J Fry, Nirali N Shah, Rimas J Orentas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2020
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell TrialNirali N Shah, Steven L Highfill, Haneen Shalabi, et al.Journal for Immunotherapy of Cancer|June 5, 2026
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial resultsSara K Silbert, Flavia Gava, Bonnie Yates, et al.The Lancet. Haematology|September 9, 2022
Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort studySara Ghorashian, Elad Jacoby, Barbara De Moerloose, et al.Transplantation and Cellular Therapy|January 12, 2022
Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow TransplantationLoredana Ruggeri, Dirk-Jan Eikema, Attilio Bondanza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trialPeter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.Bone Marrow Transplantation|May 4, 2018
Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantationMohamad Mohty, Rafael F Duarte, Jurgen Kuball, et al.Bone Marrow Transplantation|April 12, 2019
Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donorsLori Wiener, Jennifer A Hoag, Wendy Pelletier, et al.Pageof 41